Rakovina Therapeutics Inc presents promising research results at the European Workshop on Cell Death
Rakovina Therapeutics Inc (TSX-V:RKV), which is developing new cancer treatments based on novel DNA-damage response (DDR) technologies, presented promising...
Source: proactiveinvestors.com